Form 8-K - Current report:
SEC Accession No. 0001104659-25-010132
Filing Date
2025-02-06
Accepted
2025-02-06 16:31:41
Documents
15
Period of Report
2025-01-31
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 5.01: Changes in Control of Registrant
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm255614d1_8k.htm   iXBRL 8-K 47234
2 EXHIBIT 10.1 tm255614d1_ex10-1.htm EX-10.1 164284
3 EXHIBIT 10.2 tm255614d1_ex10-2.htm EX-10.2 8766
  Complete submission text file 0001104659-25-010132.txt   444192

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA fwbi-20250131.xsd EX-101.SCH 3027
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE fwbi-20250131_lab.xml EX-101.LAB 34240
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE fwbi-20250131_pre.xml EX-101.PRE 22367
17 EXTRACTED XBRL INSTANCE DOCUMENT tm255614d1_8k_htm.xml XML 3685
Mailing Address 777 YAMATO ROAD SUITE 502 BOCA RATON FL 33431
Business Address 777 YAMATO ROAD SUITE 502 BOCA RATON FL 33431 561-589-7020
Entero Therapeutics, Inc. (Filer) CIK: 0001604191 (see all company filings)

EIN.: 464993860 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37853 | Film No.: 25597879
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)